Ross Haghighat - Net Worth and Insider Trading

Ross Haghighat Net Worth

The estimated net worth of Ross Haghighat is at least $239,090 dollars as of 2025-01-16. Ross Haghighat is the Director of Aduro Biotech Inc and owns about 16,376 shares of Aduro Biotech Inc (ADRO) stock worth over $239,090. Details can be seen in Ross Haghighat's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ross Haghighat has not made any transactions after 2016-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Ross Haghighat

Ross Haghighat Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ross Haghighat owns 7 companies in total, including Aduro Biotech Inc (ADRO) , CITIC Capital Acquisition Corp (CCAC.U) , and Chinook Therapeutics Inc (KDNY) among others .

Click here to see the complete history of Ross Haghighat’s form 4 insider trades.

Insider Ownership Summary of Ross Haghighat

Ticker	Comapny	Transaction Date	Type of Owner
ADRO	Aduro Biotech Inc	2020-10-06	director
CCAC.U	CITIC Capital Acquisition Corp	2020-05-07	director
KDNY	Chinook Therapeutics Inc	2018-06-06	director
		2020-05-07	director
		2021-12-02	director & CEO and CFO
		2022-09-16	director & Co-Chief Executive Officer
		2022-09-16	director & Co-Chief Executive Officer

Ross Haghighat Latest Holdings Summary

Ross Haghighat currently owns a total of 1 stock. Ross Haghighat owns 16,376 shares of Aduro Biotech Inc (ADRO) as of November 14, 2016, with a value of $239,090.

Latest Holdings of Ross Haghighat

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ADRO	Aduro Biotech Inc	2016-11-14	16,376	14.60	239,090

Holding Weightings of Ross Haghighat

Ross Haghighat Form 4 Trading Tracker

According to the SEC Form 4 filings, Ross Haghighat has made a total of 0 transactions in Aduro Biotech Inc (ADRO) over the past 5 years. The most-recent trade in Aduro Biotech Inc is the sale of 1,418 shares on November 14, 2016, which brought Ross Haghighat around $109,864.

Insider Trading History of Ross Haghighat

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ross Haghighat Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ross Haghighat Ownership Network

Ownership Network List of Ross Haghighat

No Data

Ownership Network Relation of Ross Haghighat

Ross Haghighat Owned Company Details

What does Aduro Biotech Inc do?

Who are the key executives at Aduro Biotech Inc?

Ross Haghighat is the director of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include director & President & CEO Eric Dobmeier , 10 percent owner Versant Voyageurs I, L.p. , and 10 percent owner Versant Voyageurs I Parallel, L.p. .

Aduro Biotech Inc (ADRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aduro Biotech Inc Insider Transactions

No Available Data

What does CITIC Capital Acquisition Corp do?

Who are the key executives at CITIC Capital Acquisition Corp?

Ross Haghighat is the director of CITIC Capital Acquisition Corp. Other key executives at CITIC Capital Acquisition Corp include 10 percent owner Gem Global Yield Fund Llc , 10 percent owner Gem Global Yield Llc Scs , and Chief Human Resources Officer Lori S Sundberg .

CITIC Capital Acquisition Corp (CCAC.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CITIC Capital Acquisition Corp (CCAC.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CITIC Capital Acquisition Corp (CCAC.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CITIC Capital Acquisition Corp (CCAC.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

CITIC Capital Acquisition Corp Insider Transactions

No Available Data

What does Chinook Therapeutics Inc do?

Who are the key executives at Chinook Therapeutics Inc?

Ross Haghighat is the director of Chinook Therapeutics Inc. Other key executives at Chinook Therapeutics Inc include Head of Renal Discovery Andrew James King , director & President & CEO Eric Dobmeier , and director & 10 percent owner Davis Jerel .

Chinook Therapeutics Inc (KDNY) Insider Trades Summary

Over the past 18 months, Ross Haghighat made no insider transaction in Chinook Therapeutics Inc (KDNY). Other recent insider transactions involving Chinook Therapeutics Inc (KDNY) include a net sale of 1,168 shares made by Andrew James King ,

In summary, during the past 3 months, insiders sold 0 shares of Chinook Therapeutics Inc (KDNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168 shares of Chinook Therapeutics Inc (KDNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,168 shares.

Chinook Therapeutics Inc (KDNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chinook Therapeutics Inc Insider Transactions

No Available Data

What does Quanergy Systems Inc do?

Who are the key executives at Quanergy Systems Inc?

Ross Haghighat is the director of Quanergy Systems Inc. Other key executives at Quanergy Systems Inc include 10 percent owner Gem Global Yield Fund Llc , 10 percent owner Gem Global Yield Llc Scs , and Chief Human Resources Officer Lori S Sundberg .

Quanergy Systems Inc (QNGYQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Quanergy Systems Inc (QNGYQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Quanergy Systems Inc (QNGYQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Quanergy Systems Inc (QNGYQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Quanergy Systems Inc Insider Transactions

No Available Data

What does BioPlus Acquisition Corp do?

Who are the key executives at BioPlus Acquisition Corp?

Ross Haghighat is the director & CEO and CFO of BioPlus Acquisition Corp. Other key executives at BioPlus Acquisition Corp include 10 percent owner Steven C. Fletcher , 10 percent owner Explorer Parent Llc , and 10 percent owner Founder Holdings Llc .

BioPlus Acquisition Corp (BIOS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BioPlus Acquisition Corp (BIOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioPlus Acquisition Corp (BIOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BioPlus Acquisition Corp (BIOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioPlus Acquisition Corp Insider Transactions

No Available Data

What does Epiphany Technology Acquisition Corp do?

Who are the key executives at Epiphany Technology Acquisition Corp?

Ross Haghighat is the director & Co-Chief Executive Officer of Epiphany Technology Acquisition Corp. Other key executives at Epiphany Technology Acquisition Corp include director & Chairman Coviello Arthur W Jr , director & Vice Chairman Paul F Deninger , and 10 percent owner Steven C. Fletcher .

Epiphany Technology Acquisition Corp (EPHY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epiphany Technology Acquisition Corp (EPHY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epiphany Technology Acquisition Corp (EPHY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epiphany Technology Acquisition Corp (EPHY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epiphany Technology Acquisition Corp Insider Transactions

No Available Data

What does Epiphany Technology Acquisition Corp do?

Who are the key executives at Epiphany Technology Acquisition Corp?

Epiphany Technology Acquisition Corp (EPHYU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epiphany Technology Acquisition Corp (EPHYU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epiphany Technology Acquisition Corp (EPHYU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epiphany Technology Acquisition Corp (EPHYU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epiphany Technology Acquisition Corp Insider Transactions

No Available Data

Ross Haghighat Mailing Address

Above is the net worth, insider trading, and ownership report for Ross Haghighat. You might contact Ross Haghighat via mailing address: C/o Aduro Biotech, Inc., 626 Bancroft Way, 3c, Berkeley Ca 94710.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.